Companion Animal Product & Promotions Guide

April 2020

Animal Health Solution - a Henry Schein Animal Health magazine for veterinary professionals

Issue link: https://www.e-digitaleditions.com/i/1222383

Contents of this Issue

Navigation

Page 8 of 19

1 Grosenbaugh DA, De Luca K, Durand P-Y et al. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters. BMC Veterinary Research. 2018;14:312. https://doi.org/10.1186/ s12917-018-1625-7. Accessed November 7, 2018. 2 Rice Conlon JA, Mather TN, Tanner P. Effi cacy of a nonadjuvanted outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi.* Vet Ther. 2000;1(2):98-107. Grosenbaugh DA, De Luca K, Durand P-Y et al. Characterization of recombinant OspA in vaccines with respect to immunological response and its relationship 2018;14:312. https://doi.org/10.1186/ Rice Conlon JA, Mather TN, Tanner P. Effi cacy of a nonadjuvanted outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia TARGETED TARGETED LYME LYME PROTECTION PROTECTION THE ONLY canine Lyme vaccine that is nonadjuvanted and contains a single protein, lipidated OspA A lipidated form of OspA has been shown to be more immunogenic than a nonlipidated form of OspA 1 Effective protection that blocks Borrelia burgdorferi while it's still in the tick 2 RECOMBITEK ® RECOMBITEK Lyme has all the protection dogs need, and none of the antigens they don't. TARGETED LYME PROTECTION MEANS MEANS MEANS PURE. PURE. PURE. PURE. PURE. RECOMBITEK ® is a registered trademark of Boehringer Ingelheim Animal Health USA Inc. ©2019 Boehringer Ingelheim Animal Health USA Inc. All rights reserved. PET-0911-REC0119. A Boehringer Ingelheim Vaccine PetVaccinesClinic.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Companion Animal Product & Promotions Guide - April 2020